Centiva Capital »

Fulcrum Therapeutics shares owned by Centiva Capital

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $273k 77k 3.57
2024-03-31 $407k 43k 9.44
2023-09-30 $48k 11k 4.44

More positions owned by Centiva Capital

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Apple Call Option (AAPL)
Amazon (AMZN)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
United States Steel Corporation Call Option (X)
Kellogg Company (K)
EQT Corporation Call Option (EQT)
Agnc Invt Corp Com reit Call Option (AGNC)
Crown Castle Intl (CCI)

View all positions for Centiva Capital

Top funds holding Fulcrum Therapeutics

RA Capital Management
TCG Crossover Management
BlackRock
Nantahala Capital Management
Suvretta Capital Management
Vanguard Group
Adage Capital Partners GP
Morgan Stanley
Dimensional Fund Advisors
Woodline Partners
Geode Capital Management
State Street Corporation
Northern Trust
D. E. Shaw & Co
Goldman Sachs Group

View all funds holding Fulcrum Therapeutics